U.S. flag An official website of the United States government.
Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Morbidity and Mortality Weekly Report (MMWR)

CDC Stacks Public Health Publications

The Morbidity and Mortality Weekly Report (MMWR) series are CDC’s primary vehicle for scientific publication of timely, reliable, authoritative, accurate, objective, and useful public health information and recommendations. The MMWR series includes the following publications: MMWR Weekly, MMWR Recommendations and Reports, CDC Surveillance Summaries and MMWR Supplements. These journals are freely available to the public as Diamond Open Access. For more on MMWR, visit https://www.cdc.gov/mmwr/index.html.

(7)
(66)
(183)
(226)
(498)
(673)
(659)
(405)
(489)
(557)
(246)
(325)
(419)
(393)
(80)
(145)
(99)
(110)
(97)
(92)
(118)
(92)
(108)
(96)
(97)
(92)
(79)
(95)
(87)
(91)
(88)
(76)
(74)
(84)
(80)
(69)
(70)
(73)
(68)
(69)
(59)
(67)
(62)
(64)
(62)
(66)
(72)
(55)
(53)
(55)
(60)
(56)
(58)
(54)
(53)
(56)
(55)
(52)
(54)
(53)
(54)
(54)
(53)
(53)
(53)
(53)
(54)
(53)
(53)
(53)
(53)
(54)
(53)
(53)
(51)
0 of 75
(2)
(1)
(388)
(2)
(8)
(3014)
(5)
(2879)
(13)
(52)
(86)
(5)
(1)
(4)
(2)
(19)
(13)
(71)
(2670)
(3)
(4)
0 of 21
(1)
(2)
(16)
(31)
(13)
(1)
(8)
(2)
(2)
(4)
(5)
(25)
(1)
(7)
(2)
(171)
(1)
(104)
(2)
(3)
(7)
(1)
(3)
(10)
(9)
(1)
(1)
(5)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(14)
(159)
(157)
(1)
(1)
(1)
(1)
(16)
(1)
(27)
(2)
(22)
(2)
(1)
(1)
(1)
(1)
(23)
(8)
(1)
(2)
(3)
(1)
(6)
(1)
(19)
(1)
(7)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(7)
(1)
(3)
(2)
(1)
(2)
(1)
(1)
(1)
(1)
(12)
(1)
(1)
(1)
(2)
(1)
(16)
(1)
(4)
(1)
(20)
(1)
(5)
(5)
(1)
(1)
(1)
(1)
(1)
(2)
(4)
(1)
(2)
(2)
(2)
(1)
(833)
(2)
(1)
(11)
(1)
(1)
(3)
(7)
(1)
(1)
(1)
(88)
(4)
(1)
(1)
(1)
(1)
(8)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(3)
(2)
(1)
(1)
(10)
(3)
(53)
(1)
(2)
(1)
(1)
(1)
(8)
(16)
(1)
(1)
(1)
(1)
(7)
(1)
(5)
(253)
(1)
(7)
(1)
(1)
(3)
(182)
(2)
(2)
(1)
(1)
(4)
(2)
(1)
(1)
(9)
(1)
(1)
(1)
(1)
(9)
(1)
(1)
(1)
(1)
(2)
(2)
(40)
(1)
(1)
(9)
(13)
(1)
(5)
(1)
(2)
(11)
(1)
(1)
(122)
(2)
(1)
(1)
(1)
(4)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(2)
(1)
(4)
(1)
(7)
(1)
(1)
(1)
(3)
(67)
(1)
(1)
(1)
(1)
(1)
(2)
(13)
(35)
(2)
(1)
(1)
(5)
(3)
(12)
(307)
(1)
(1)
(1)
(1)
(27)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(274)
(3)
(8)
(42)
(3)
(12)
(5)
(1)
(4)
(8)
(1)
(1)
(20)
(1)
(8)
(1)
(1)
(1)
(3)
(2)
(14)
(14)
(9)
(2)
(19)
(1)
(108)
(1)
(1)
(1)
(1)
(4)
(5)
(23)
(1)
(1)
(9)
(3)
(75)
(1)
(295)
(1)
(1)
(1)
(31)
(159)
(12)
(1)
(161)
(3)
(3)
(10)
(8)
(23)
(2)
(1)
(1)
(1)
(4)
(23)
(42)
(1)
(1)
(1)
(1)
(108)
(1)
(1)
(1)
(1)
(210)
(18)
(1)
(1)
(9)
(2)
(1)
(3)
(1)
(1)
(1)
(1)
(7)
(4)
(1)
(1)
(1)
(1)
(5)
(37)
(1)
(1)
(1)
(1)
(2)
(3)
(1)
(12)
(1)
(3)
(96)
(1)
(1)
(2)
(4)
(5)
(206)
(1)
(2)
(3)
(1)
(1)
(117)
(10)
(7)
(2)
(2)
(1)
(1)
(1)
(3)
(2)
(1)
(1)
(1)
(1)
(183)
(1)
(1)
(249)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(54)
(1)
(1)
(1)
(1)
(5)
(249)
(12)
(5)
(3)
(11)
(1)
(8)
(3)
(1)
(1)
(1)
(3)
(1)
(288)
(3)
(1)
(1)
(131)
(2)
(1)
(160)
(1)
(1)
(1)
(75)
(4)
(3)
(1)
(1)
(1)
(1)
(8)
(1)
(1)
(2)
(1)
(4)
(1)
(2)
(3)
(3)
(112)
(1)
(1)
(8)
(2)
(27)
(36)
(2)
(1)
(1)
(3)
(1)
(18)
(1)
(5)
(3)
(3)
(52)
(1)
(218)
(2)
(1)
(1)
(185)
(2)
(1)
(5)
(1)
(480)
(1)
(6)
(2)
(16)
(1)
(4)
(1)
(5)
(156)
(1)
(1)
(6)
(3)
(9)
(3)
(31)
(1)
(1)
(3)
(1)
(234)
(1)
(47)
(1)
(2)
(4)
(1)
(9)
(8)
(1)
(5)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(332)
(112)
(1)
(1)
(3)
(10)
(1)
(1)
(260)
(1)
(34)
(57)
(48)
(63)
(98)
(43)
(24)
(29)
(61)
(48)
(1)
(1)
(1)
(1)
(1)
(3)
(5)
(8)
(30)
(7)
(7)
(3)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(289)
(1)
(1)
(13)
(10)
(2)
(27)
(1)
(1)
(1)
(1)
(19)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(19)
(1)
(1)
(1)
(5)
(16)
(1)
(2)
(1)
(153)
(1)
(1)
(1)
(5)
(1)
(9)
(1)
(1)
(3)
(2)
(1)
(89)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(1)
(5)
(4)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(5)
(1)
(1)
(1)
(1)
(3)
(11)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(3)
(3)
(1)
(4)
(1)
(4)
(1)
(1)
(1)
(8)
(1)
(1)
(1)
(5)
(1)
(2)
(1)
(1)
(18)
(13)
(1)
(13)
(1)
(1)
(14)
(10)
(1)
(1)
(1)
(113)
(45)
(8)
(2)
(1)
(5)
(1)
(8)
(4)
(19)
(1)
(2)
(2)
(1)
(5)
(2)
(1)
(2)
(1)
(13)
(1)
(1)
(1)
(1)
(2)
(2)
(22)
(24)
(1)
(1)
(1)
(3)
(1)
(17)
(1)
(1)
(11)
(1)
(1)
(1)
(1)
(1)
(182)
(1)
(1)
(458)
(22)
(1)
(1)
(3)
(2)
(1)
(1)
(1)
(1)
(11)
(8)
(1)
(1)
(1)
(7)
(1)
(1)
(143)
(1)
(22)
(1)
(1)
(66)
(7157)
(11)
(1)
(1)
(5)
(10)
(146)
(1)
(1)
(11)
(79)
(1)
(1)
(3)
(31)
(3)
(1)
(4)
(208)
(4)
(2)
(1)
(1)
(30)
(2)
(1)
(370)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(2)
(1)
(1)
(1)
(1)
(105)
(1)
(1)
(183)
(1)
(1)
(2)
(1)
(44)
(1)
(3)
(9)
(6)
(9)
(10)
(1)
0 of 775
(6)
(62)
(187)
(218)
(499)
(662)
(656)
(411)
(483)
(558)
(231)
(311)
(429)
(404)
(81)
(138)
(97)
(104)
(102)
(92)
(119)
(92)
(104)
(97)
(97)
(91)
(80)
(95)
(86)
(90)
(87)
(76)
(74)
(84)
(80)
(69)
(70)
(71)
(69)
(64)
(60)
(68)
(62)
(62)
(62)
(67)
(72)
(56)
(55)
(54)
(59)
(57)
(58)
(54)
(53)
(55)
(55)
(55)
(53)
(53)
(53)
(53)
(54)
(53)
(53)
(53)
(53)
(53)
(54)
(54)
(53)
(53)
(53)
(53)
(54)
0 of 75
(1)
(7)
(33)
(71)
(44)
(137)
(157)
(160)
(151)
(137)
(161)
(169)
(155)
(159)
(160)
(156)
(162)
(164)
(156)
(164)
(156)
(172)
(141)
(155)
(158)
(133)
(154)
(140)
(140)
(139)
(135)
(137)
(141)
(128)
(156)
(142)
(135)
(151)
(151)
(175)
(205)
(196)
(163)
(186)
(179)
(200)
(204)
(201)
(220)
(225)
(231)
(219)
(224)
(253)
(255)
(278)
0 of 56
(2)
(1)
(5)
(1)
(430)
(107)
(399)
(8468)
0 of 8
(16)
(34)
(1)
(6)
(1)
0 of 5
(10)
(10)
(23)
(11)
(17)
(23)
(32)
(55)
(12)
(31)
(8)
(37)
(7)
(35)
(1053)
(18)
(1076)
(29)
(73)
(10)
(91)
(26)
(14)
(6)
(651)
(168)
(24)
(79)
(53)
(15)
(47)
(10)
(11)
(10)
(17)
(36)
(18)
(24)
(6)
(15)
(21)
(11)
(14)
(10)
(7)
(46)
(11)
(151)
(16)
(17)
(8)
(172)
(138)
(129)
(30)
(16)
(11)
(8)
(10)
(12)
(14)
(6)
(6)
(8)
(6)
(14)
(7)
(28)
(14)
(10)
(7)
(17)
(100)
(13)
(11)
(35)
(14)
(12)
(7)
(10)
(10)
(20)
(6)
(8)
(6)
(8)
(14)
(19)
(6)
(11)
(8)
(6)
(15)
(73)
(6)
(10)
(62)
(7)
(6)
(11)
(9)
(13)
(11)
(16)
(69)
(6)
(14)
(23)
(11)
(29)
(28)
(12)
(187)
(7)
(7)
(16)
(18)
(52)
(6)
(7)
(11)
(19)
(20)
(7)
(6)
(11)
(6)
(10)
(6)
(21)
(12)
(29)
(19)
(20)
(7)
(12)
(11)
(26)
(63)
(10)
(38)
(27)
(11)
(6)
(17)
(6)
(7)
(8)
(13)
(28)
(21)
(9)
(781)
(593)
(8)
(12)
(6)
(14)
(33)
(6)
(6)
(99)
(10)
(43)
(10)
(16)
(8)
(11)
(9)
(51)
(10)
(6)
(20)
(13)
(31)
(17)
(18)
(18)
(18)
(7)
(7)
(6)
(14)
(177)
(69)
(6)
(6)
(2920)
(37)
(12)
(834)
(281)
(173)
(33)
(7)
(23)
(27)
(13)
(17)
(6)
(14)
(12)
(26)
(10)
(69)
(14)
(9)
(8)
(7)
(21)
(8)
(27)
(448)
(18)
(23)
(15)
(8)
(75)
(26)
(19)
(8)
(15)
(15)
(14)
(45)
(681)
(8)
(7)
(15)
(6)
(59)
(203)
(7)
(6)
(10)
(18)
(8)
(12)
(67)
(25)
(14)
(38)
(70)
(7)
(6)
(11)
(8)
(6)
(20)
(6)
(18)
(21)
(50)
(8)
(8)
(13)
(7)
(24)
(28)
(80)
(7)
(9)
(9)
(7)
(20)
(59)
(8)
(8)
(13)
(25)
(25)
(12)
(8)
(7)
(166)
(22)
(14)
(34)
(23)
(10)
(11)
(9)
(20)
(17)
(12)
(91)
(4154)
(509)
(21)
(15)
(7)
(10)
(14)
(10)
(9)
(8)
(22)
(13)
(17)
(8)
(8)
(11)
(19)
(10)
(14)
(43)
(20)
(27)
(22)
(10)
(20)
(19)
(8)
(60)
(7)
(91)
(17)
(9)
(18)
(8)
(13)
(23)
(8)
(25)
(45)
(65)
(21)
(148)
(8)
(7)
(12)
(7)
(31)
(16)
(13)
(19)
(17)
(16)
(22)
(10)
(7)
(11)
(117)
(40)
(18)
(7)
(41)
(31)
(13)
(638)
(52)
(7)
(16)
(9)
(56)
(7)
(14)
(125)
(18)
(63)
(8)
(10)
(10)
(22)
(9)
(10)
(9)
(18)
(14)
(21)
(85)
(23)
(1103)
(14)
(13)
(11)
(11)
(7)
(8)
(47)
(7)
(21)
(183)
(31)
(21)
(16)
(40)
(12)
(9)
(8)
(618)
(393)
(14)
(7)
(18)
(14)
(119)
(15)
(51)
(7)
(7)
(22)
(10)
(14)
(10)
(7)
(86)
(9)
(64)
(50)
(47)
(56)
(16)
(22)
(44)
(117)
(7)
(19)
(81)
(53)
(8)
(27)
(125)
(32)
(85)
(16)
(7)
(8)
(11)
(7)
(7)
(10)
(46)
(66)
(116)
(29)
(7)
(171)
(24)
(8)
(14)
(49)
(7)
(9)
(27)
(10)
(45)
(7)
(11)
(8)
(8)
(53)
(31)
(76)
(43)
(15)
(147)
(8)
(9)
(23)
(11)
(10)
(9)
(8)
(7)
(28)
(46)
(7)
(201)
(8)
(29)
(13)
(12)
(2179)
(14)
(15)
(16)
(7)
(100)
(18)
(37)
(8)
(7)
(157)
(215)
(21)
(8)
(8)
(18)
(194)
(9)
(46)
(544)
(9)
(259)
(14)
(44)
(51)
(23)
(16)
(20)
(584)
(7)
(13)
(42)
(19)
(10)
(37)
(25)
(22)
(21)
(188)
(21)
(54)
(48)
(114)
(29)
(8)
(105)
(22)
(10)
(11)
(7)
(11)
(7)
(28)
(20)
(12)
(7)
(17)
(9)
(62)
(15)
(11)
(10)
(68)
(9)
(10)
(7)
(70)
(110)
(40)
(17)
(55)
(17)
(7)
(9)
(18)
(9)
(7)
(14)
(35)
(49)
(10)
(11)
(9)
(173)
(16)
(12)
(13)
(966)
(9)
(8)
(39)
(9)
(43)
(86)
(16)
(19)
(297)
(34)
(30)
(21)
(14)
(77)
(12)
(17)
(7)
(18)
(8)
(7)
(8)
(7)
(19)
(58)
(32)
(82)
(14)
(37)
(8)
(18)
(36)
(8)
(7)
(13)
(14)
(9)
(65)
(19)
(795)
(96)
(14)
(39)
(28)
(15)
(7)
(43)
(3794)
(9)
(31)
(16)
(21)
(14)
(12)
(12)
(16)
(10)
(9)
(9)
(8)
(11)
(18)
(8)
(14)
(14)
(9)
(14)
(7)
(35)
(7)
(34)
(18)
(9)
(27)
(11)
(9)
(8)
(249)
(18)
(15)
(28)
(11)
(105)
(229)
(570)
(69)
(7)
(11)
(21)
(7)
(7)
(11)
(15)
(8)
(7)
(297)
(13)
(8)
(10)
(8)
(7)
(14)
(11)
(12)
(7)
(9)
(19)
(10)
(9)
(13)
(13)
(13)
(7)
(10)
(18)
(10)
(48)
(7)
(9)
(9)
(9)
(9)
(19)
(7)
(7)
(143)
(13)
(26)
(143)
(11)
(171)
(10)
(8)
(8)
(22)
(65)
(338)
(111)
(86)
(22)
(34)
(11)
(31)
(12)
(25)
(16)
(22)
(17)
(7)
(1040)
(16)
(27)
(16)
(15)
(100)
(13)
(21)
(20)
(288)
(10)
(18)
(70)
(16)
(13)
(19)
(14)
(27)
(7)
(24)
(9)
(8)
(10)
(161)
(51)
(7)
(14)
(16)
(7)
(34)
(21)
(10)
(13)
(60)
(7)
(12)
(8)
(233)
(929)
(18)
(10)
(19)
(67)
(101)
(2531)
(10)
(104)
(12)
(23)
(12)
(16)
(11)
(92)
(179)
(38)
(275)
(15)
(8)
(8)
(13)
(43)
(24)
(87)
(9)
(16)
(18)
(20)
(15)
(65)
(29)
(18)
(11)
(8)
(12)
(21)
(10)
(26)
(9)
(8)
(8)
(20)
(95)
(176)
(7)
(28)
(21)
(25)
(10)
(19)
(9)
(51)
(47)
(167)
(236)
(8)
(14)
(10)
(21)
(12)
(57)
(15)
(32)
(9)
(31)
(537)
(23)
(29)
(145)
(240)
(7)
(11)
(175)
(10)
(18)
(10)
(105)
(8)
(10)
(90)
(16)
(15)
(7)
(12)
(18)
(11)
(9)
(14)
(10)
(18)
(12)
(37)
(11)
(41)
(21)
(7)
(16)
(31)
(25)
(14)
(10)
(11)
(12)
(80)
(27)
(8)
(35)
(8)
(20)
(16)
(7)
(7)
(10)
(184)
(9)
(28)
(15)
(62)
(8)
(18)
(19)
(14)
(8)
(9)
(73)
(16)
(16)
(33)
(16)
(7)
(134)
(51)
(10)
(14)
(56)
(8)
(10)
(14)
(90)
(26)
(29)
(11)
(46)
(7)
(7)
(39)
(72)
(8)
(7)
(22)
(11)
(181)
(10)
(7)
(7)
(18)
(30)
(17)
(7)
(20)
(7)
(12)
(7)
(68)
(8)
(52)
(12)
(11)
(8)
(15)
(8)
(8)
(60)
(16)
(160)
(28)
(35)
(22)
(106)
(15)
(144)
(13)
(7)
(7)
(15)
(68)
(9)
(14)
(182)
(10)
(10)
(19)
(49)
(17)
(28)
(17)
(37)
(17)
(18)
(14)
(439)
(11)
(36)
(101)
(17)
(95)
(28)
(22)
(32)
(21)
(39)
(10)
(24)
(27)
(19)
(35)
(21)
(10)
(17)
(8)
(38)
(71)
(7)
(20)
(24)
(9)
(20)
(9)
(10)
(7)
(32)
(13)
(14)
(50)
(8)
(37)
(10)
(39)
(10)
(58)
(9)
(38)
(9)
(13)
(46)
(27)
(755)
(30)
(57)
(10)
(12)
(17)
0 of 1000
(12)
(12)
(15)
(7)
(23)
(9)
(7)
(20)
(8)
(7)
(12)
(14)
(7)
(9)
(7)
(10)
(9)
(12)
(11)
(19)
(9)
(11)
(9)
(10)
(27)
(8)
(9)
(16)
(23)
(15)
(11)
(7)
(7)
(7)
(9)
(13)
(11)
(10)
(15)
(8)
(7)
(9)
(7)
(7)
(7)
(9)
(8)
(19)
(9)
(9)
(7)
(7)
(13)
(7)
(7)
(9)
(7)
(9)
(7)
(16)
(11)
(7)
(12)
(13)
(22)
(29)
(15)
(10)
(7)
(13)
(7)
(19)
(12)
(12)
(13)
(15)
(17)
(10)
(7)
(11)
(27)
(7)
(13)
(28)
(7)
(10)
(11)
(11)
(13)
(10)
(8)
(18)
(9)
(10)
(16)
(29)
(11)
(12)
(13)
(13)
(8)
(9)
(7)
(28)
(9)
(16)
(8)
(31)
(7)
(7)
(8)
(8)
(11)
(16)
(16)
(12)
(35)
(8)
(11)
(16)
(18)
(9)
(29)
(9)
(16)
(22)
(31)
(10)
(7)
(8)
(10)
(18)
(9)
(7)
(9)
(7)
(7)
(7)
(11)
(9)
(23)
(20)
(10)
(7)
(7)
(15)
(10)
(8)
(36)
(8)
(22)
(10)
(16)
(8)
(11)
(10)
(24)
(13)
(8)
(11)
(7)
(9)
(11)
(9)
(12)
(21)
(9)
(9)
(7)
(11)
(7)
(15)
(9)
(7)
(9)
(12)
(20)
(12)
(7)
(11)
(8)
(7)
(10)
(10)
(7)
(9)
(24)
(7)
(8)
(10)
(12)
(8)
(13)
(25)
(24)
(7)
(24)
(17)
(9)
(7)
(10)
(10)
(12)
(8)
(13)
(9)
(9)
(10)
(7)
(10)
(7)
(19)
(8)
(9)
(7)
(16)
(17)
(11)
(10)
(12)
(9)
(12)
(7)
(10)
(7)
(9)
(9)
(14)
(8)
(8)
(12)
(25)
(7)
(18)
(9)
(12)
(15)
(7)
(7)
(17)
(17)
(8)
(16)
(7)
(8)
(20)
(7)
(8)
(11)
(12)
(21)
(10)
(11)
(10)
(13)
(9)
(8)
(7)
(12)
(8)
(15)
(9)
(11)
(7)
(17)
(12)
(18)
(18)
(7)
(18)
(24)
(11)
(7)
(7)
(12)
(8)
(20)
(20)
(16)
(11)
(12)
(7)
(8)
(10)
(7)
(14)
(16)
(7)
(9)
(12)
(20)
(15)
(9)
(16)
(48)
(9)
(11)
(24)
(10)
(8)
(8)
(7)
(9)
(9)
(7)
(10)
(8)
(53)
(13)
(10)
(11)
(15)
(42)
(16)
(7)
(8)
(7)
(29)
(10)
(8)
(10)
(8)
(8)
(24)
(8)
(12)
(12)
(8)
(13)
(21)
(23)
(10)
(10)
(15)
(20)
(11)
(10)
(15)
(17)
(11)
(18)
(7)
(17)
(16)
(9)
(15)
(18)
(7)
(14)
(16)
(7)
(20)
(7)
(9)
(17)
(12)
(15)
(8)
(18)
(20)
(15)
(11)
(29)
(7)
(10)
(23)
(7)
(7)
(28)
(8)
(7)
(26)
(18)
(7)
(12)
(11)
(8)
(36)
(15)
(12)
(7)
(8)
(15)
(16)
(7)
(9)
(10)
(9)
(17)
(7)
(12)
(12)
(14)
(12)
(16)
(10)
(13)
(8)
(15)
(23)
(8)
(8)
(8)
(13)
(7)
(17)
(9)
(7)
(30)
(12)
(15)
(13)
(9)
(7)
(7)
(9)
(8)
(7)
(7)
(8)
(14)
(9)
(14)
(17)
(7)
(8)
(7)
(10)
(11)
(7)
(16)
(10)
(60)
(12)
(9)
(8)
(7)
(7)
(9)
(7)
(18)
(7)
(10)
(18)
(9)
(16)
(10)
(8)
(26)
(11)
(8)
(9)
(14)
(26)
(24)
(8)
(43)
(11)
(14)
(7)
(15)
(11)
(21)
(7)
(28)
(15)
(10)
(9)
(25)
(18)
(7)
(8)
(8)
(7)
(7)
(18)
(15)
(15)
(11)
(7)
(8)
(7)
(10)
(12)
(9)
(30)
(16)
(7)
(9)
(20)
(18)
(15)
(9)
(7)
(7)
(8)
(13)
(11)
(15)
(17)
(8)
(49)
(7)
(32)
(13)
(10)
(16)
(7)
(23)
(24)
(9)
(10)
(25)
(8)
(20)
(7)
(7)
(13)
(7)
(11)
(9)
(8)
(7)
(8)
(10)
(9)
(8)
(13)
(7)
(7)
(10)
(16)
(14)
(11)
(7)
(10)
(20)
(9)
(15)
(7)
(7)
(11)
(12)
(11)
(13)
(9)
(7)
(19)
(25)
(17)
(8)
(15)
(9)
(9)
(18)
(17)
(8)
(8)
(12)
(7)
(10)
(7)
(9)
(8)
(18)
(18)
(11)
(8)
(34)
(21)
(7)
(18)
(9)
(7)
(10)
(7)
(10)
(9)
(14)
(16)
(8)
(25)
(12)
(7)
(53)
(7)
(7)
(7)
(19)
(8)
(10)
(10)
(7)
(10)
(9)
(8)
(8)
(20)
(11)
(27)
(8)
(8)
(19)
(7)
(19)
(7)
(11)
(8)
(7)
(15)
(7)
(11)
(11)
(28)
(10)
(9)
(7)
(20)
(10)
(14)
(7)
(8)
(9)
(13)
(11)
(10)
(7)
(13)
(9)
(8)
(10)
(8)
(7)
(7)
(10)
(9)
(14)
(9)
(39)
(23)
(10)
(8)
(7)
(10)
(11)
(10)
(13)
(15)
(10)
(7)
(17)
(10)
(7)
(7)
(11)
(11)
(12)
(10)
(18)
(14)
(8)
(10)
(21)
(16)
(15)
(14)
(9)
(15)
(10)
(19)
(24)
(11)
(20)
(21)
(16)
(7)
(7)
(10)
(23)
(7)
(8)
(17)
(7)
(9)
(11)
(8)
(7)
(18)
(8)
(7)
(7)
(9)
(9)
(14)
(10)
(8)
(13)
(9)
(13)
(8)
(18)
(7)
(7)
(27)
(12)
(8)
(15)
(9)
(17)
(8)
(18)
(7)
(26)
(12)
(9)
(11)
(22)
(8)
(10)
(7)
(7)
(13)
(8)
(7)
(8)
(10)
(21)
(15)
(15)
(35)
(18)
(7)
(7)
(8)
(20)
(16)
(24)
(23)
(18)
(9)
(7)
(19)
(9)
(7)
(7)
(13)
(26)
(7)
(7)
(12)
(11)
(19)
(8)
(27)
(17)
(10)
(10)
(8)
(13)
(9)
(16)
(12)
(10)
(18)
(25)
(11)
(15)
(10)
(18)
(25)
(13)
(16)
(9)
(19)
(13)
(27)
(17)
(18)
(8)
(10)
(8)
(10)
(14)
(10)
(13)
(8)
(11)
(17)
(15)
(13)
(14)
(13)
(8)
(33)
(8)
(11)
(10)
(8)
(11)
(12)
(21)
(10)
(9)
(12)
(24)
(8)
(10)
(14)
(8)
(9)
(18)
(11)
(8)
(8)
(11)
(9)
(8)
(11)
(10)
(8)
(8)
(14)
(12)
(10)
(15)
(9)
(30)
(11)
(11)
(8)
(14)
(23)
(8)
(13)
(11)
(10)
(8)
(8)
(9)
(20)
(17)
(12)
(10)
(8)
(8)
(18)
(14)
(17)
(11)
(9)
(29)
(10)
(9)
(13)
(11)
(8)
(29)
(13)
(13)
(9)
(11)
(40)
(8)
(10)
(12)
(14)
(9)
(13)
(16)
(9)
(12)
(9)
(8)
(9)
(11)
(8)
(9)
(40)
(10)
(9)
(20)
(17)
(8)
(24)
(13)
(10)
(22)
(8)
(9)
(18)
(20)
(9)
(9)
(8)
(8)
(29)
(15)
(8)
(72)
(9)
(38)
(8)
(23)
(10)
(24)
(9)
(12)
(9)
(8)
(10)
(12)
(14)
(8)
(22)
(9)
(13)
(10)
(16)
(8)
(9)
(13)
(15)
(11)
(8)
(11)
(15)
(9)
(9)
(13)
(9)
(20)
(14)
(32)
(9)
(17)
(9)
(10)
(10)
(14)
(8)
(9)
(32)
(16)
(8)
(10)
(11)
(14)
(15)
(21)
(10)
(15)
(8)
(9)
(12)
(8)
(15)
(12)
(18)
(9)
(12)
(13)
(13)
(23)
(11)
(15)
(11)
(9)
(8)
(8)
(13)
(25)
(13)
(17)
(8)
(13)
(11)
(13)
(11)
(9)
(10)
(8)
(10)
(13)
(21)
(13)
(20)
(23)
(25)
(9)
(9)
(11)
(12)
(15)
(10)
(14)
(10)
(9)
(19)
(14)
(10)
0 of 1000
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(6)
(1)
(5)
(1)
(1)
(1)
(1)
(1)
(4)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(5)
(4)
(1)
(1)
(1)
(1)
(3)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(5)
(1)
(1)
(3)
(1)
(2)
(1)
(1)
(1)
(1)
(7)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(9)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(5)
(1)
(1)
(1)
(4)
(1)
(3)
(1)
(1)
(1)
(2)
(4)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(7)
(3)
(2)
(3)
(1)
(1)
(1)
(1)
(9)
(1)
(1)
(3)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(9)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(8)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(13)
(1)
(1)
(7)
(1)
(16)
(14)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(2)
(1)
(35)
(1)
(2)
(107)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(4)
(2)
(3)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(6)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(4)
(1)
(3)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(2)
(2)
(3)
(1)
(1)
(2)
(68)
(1)
(4)
(1)
(1)
(1)
(1)
(2)
(2)
(4)
(1)
(1)
(1)
(1)
(8)
(4)
(1)
(3)
(7)
(5)
(2)
(1)
(11)
(1)
(2)
(3)
(1)
(7)
(1)
(4)
(1)
(1)
(1)
(3)
(1)
(6)
(1)
(1)
(1)
(1)
(8)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(14)
(1)
(1)
(3)
(1)
(1)
(1)
(3)
(1)
(1)
(89)
(1)
(2)
(1)
(1)
(4)
(22)
(1)
(1)
(1)
(2)
(1)
(1)
(4)
(1)
(1)
(1)
(1)
(3929)
(1)
(1)
(2)
(11)
(10)
(1)
(1)
(41)
(1)
(2)
(1)
(1)
(1)
(1)
(3)
(14)
(1)
(1)
(1)
(4)
(21)
(1)
(7)
(3)
(1)
(1)
(1)
(3)
(1)
(1)
(5)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(3)
(13)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(2)
(1)
(1)
(7)
(2)
(2)
(1)
(1)
(2)
(2)
(1)
(65)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(2)
(1)
(1)
(1)
(3)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(10)
(1)
(1)
(1)
(1)
(7)
(1)
(1)
(1)
(33)
(1)
(1)
(1)
(1)
(2)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(3)
(22)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(3)
(3)
(1)
(1)
(1)
(1)
(426)
(1)
(1)
(5)
(1)
(2)
(1)
(3)
(7)
(6)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(13)
(5)
(2)
(2)
(2)
(2)
(3)
(2)
(2)
(2)
(4)
(3)
(3)
(4)
(2)
(2)
(5)
(2)
(3)
(2)
(3)
(9)
(2)
(2)
(2)
(2)
(9)
(2)
(8)
(4)
(2)
(2)
(5)
(2)
(12)
(2)
(12)
(2)
(7)
(4)
(2)
(3)
(2)
(3)
(4)
(4)
(2)
(5)
(7)
(4)
(2)
(5)
(2)
(7)
(2)
(9)
(2)
(2)
(8)
(2)
(2)
(2)
(4)
(9)
(3)
(3)
(2)
(2)
(5)
(9)
(4)
(4)
(2)
(2)
(5)
(4)
(2)
(3)
(3)
(9)
(4)
(4)
(6)
(4)
(2)
(3)
(2)
(6)
(2)
(11)
(2)
(2)
(2)
(4)
(2)
(2)
(2)
(3)
(10)
(5)
(3)
(8)
(2)
(15)
(2)
(2)
(20)
(2)
(3)
(6)
(2)
(2)
(5)
(2)
(13)
(11)
(2)
(30)
(2)
(3)
(3)
(7)
(2)
(3)
(3)
(2)
(2)
(9)
(2)
(14)
(2)
(7)
(3)
(4)
(3)
(2)
(2)
(3)
(9)
(5)
(9)
(52)
(8)
(3)
(14)
(3)
(3)
(2)
(4)
(3)
(10)
(5)
(3)
(2)
(15)
(9)
(5)
(5)
(2)
(5)
(4)
(5)
(4)
(5)
(5)
(11)
(4)
(13)
(5)
(2)
(2)
(12)
(5)
(2)
(3)
(2)
(6)
(2)
(3)
(2)
(3)
(2)
(2)
(421)
(3)
(4)
(7)
(2)
(2)
(2)
(3)
(3)
(3)
(3)
(2)
(6)
(2)
(2)
(3)
(2)
(3)
(10)
(2)
(20)
(2)
(7)
(10)
(6)
(4)
(7)
(5)
(4)
(11)
(3)
(2)
(4)
(2)
(13)
(17)
(2)
(25)
(2)
(2)
(5)
(8)
(5)
(12)
(8)
(5)
(4)
(13)
(4)
(17)
(6)
(9)
(2)
(2)
(25)
(2)
(2)
(6)
(3)
(9)
(3)
(2)
(4)
(15)
(3)
(4)
(3)
(7)
(16)
(6)
(2)
(27)
(2)
(2)
(4)
(5)
(5)
(24)
(2)
(4)
(2)
(7)
(3)
(9)
(3)
(2)
(9)
(6)
(11)
(5)
(15)
(4)
(2)
(3)
(5)
(6)
(2)
(2)
(118)
(5)
(18)
(3)
(2)
(7)
(135)
(17)
(8)
(3)
(8)
(3)
(2)
(8)
(2)
(2)
(3)
(2)
(4)
(6)
(7)
(3)
(3)
(2)
(3)
(2)
(10)
(12)
(4)
(2)
(3)
(3)
(4)
(9)
(2)
(2)
(2)
(6)
(6)
(4)
(2)
(2)
(13)
(2)
(4)
(2)
(2)
(2)
(4)
(3)
(9)
(2)
(4)
(2)
(2)
(2)
(7)
(2)
(2)
(2)
(2)
(2)
(2)
(2)
(2)
(3)
(4)
(3)
(3)
(3)
(4)
(13)
(4)
(2)
(5)
(6)
(5)
(2)
(3)
(14)
(4)
(2)
(2)
(2)
(2)
(2)
(14)
(7)
(7)
(3)
(2)
(3)
(2)
(2)
(2)
(44)
(183)
(2)
(88)
(115)
(2)
(8)
(16)
(10)
(5)
(2)
(16)
(180)
(2)
(4)
(3)
(6)
(93)
(2)
(2)
(2)
(4)
(317)
(7)
(11)
(2)
(6)
(8)
(2)
(3)
(26)
(80)
(2)
(2)
(22)
(3)
(2)
(36)
(30)
(10)
(4)
(3)
(6)
(2)
(3)
(4)
(3)
(2)
(4)
(2)
(2)
(2)
(2)
(2)
(2)
(3)
(2)
(4)
(2)
(2)
(4)
(2)
(3)
(2)
(2)
(2)
(4)
(3)
(2)
(5)
(2)
(2)
(4)
(2)
(2)
(2)
(4)
(15)
(3)
(3)
(2)
(14)
(2)
(2)
(6)
(15)
(13)
(4)
(2)
(3)
(5)
(2)
(2)
(5)
(8)
(2)
(4)
(2)
(3)
(3)
(7)
(2)
(2)
(4)
(4)
(2)
(4)
(2)
(2)
(2)
(2)
0 of 1000
(1)
(4)
(21)
(2)
(2)
(25)
(11)
(2)
(4)
(2)
(2)
(8)
(1)
(5)
(32)
(1)
(3)
(6)
(22)
(129)
(1)
(24)
(1)
(3)
(3)
(1)
(652)
(1891)
(2)
(6)
(38)
(1)
(2)
(1)
(7)
(3)
(16)
(116)
(108)
(2)
(385)
(3)
(5)
(1)
(1)
(1)
(1)
(2)
(1)
(2300)
(1)
(5)
(1)
(7)
(367)
(4)
(6)
(51)
(3)
0 of 59
(1)
(1)
(3)
(1)
(1)
(15)
(19)
(19)
(19)
(1)
(1)
(11)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(3)
(3)
(3)
(2)
(1)
(1)
(17)
(19)
(7)
(10)
(6)
(12)
(8)
(1)
(21)
(2)
(3)
(1)
(4)
(9)
(1)
(1)
(4)
(2)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(4)
(1)
(1)
(2)
(1)
(3)
(2)
(1)
(9)
(1)
(5)
(2)
(4)
(1)
(1)
(3)
(1)
(1)
(1)
(5)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(5)
(1)
(2)
(1)
(1)
(3)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(7)
(3)
(2)
(1)
(3)
(1)
(1)
(2)
(1)
(2)
(1)
(1)
(1)
(2)
(1)
(2)
(1)
(1)
(2)
(2)
(3)
(2)
(5)
(1)
(1)
(5)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(4)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(5)
(1)
(8)
(2)
(9)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(12)
(5)
(1)
(1)
(1)
(1)
(2)
(2)
(6)
(1)
(9)
(1)
(1)
(5)
(7)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(19)
(1)
(5)
(1)
(2)
(4)
(1)
(10)
(1)
(7)
(1)
(4)
(1)
(1)
(2)
(2)
(1)
(2)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(3)
(1)
(1)
(4)
(5)
(1)
(1)
(1)
(1)
(2)
(1)
(6)
(3)
(1)
(2)
(2)
(1)
(2)
(3)
(2)
(1)
(1)
(6)
(1)
(2)
(2)
(10)
(1)
(1)
(1)
(1)
(11)
(1)
(5)
(1)
(1)
(1)
(1)
(1)
(6)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(2)
(1)
(2)
(2)
(3)
(4)
(4)
(1)
(1)
(2)
(4)
(12)
(1)
(6)
(4)
(2)
(1)
(3)
(1)
(4)
(2)
(3)
(1)
(18)
(2)
(1)
(3)
(3)
(1)
(1)
(1)
(1)
(2)
(1)
(3)
(5)
(2)
(3)
(2)
(1)
(1)
(1)
(1)
(4)
(3)
(1)
(3)
(1)
(2)
(3)
(5)
(1)
(3)
(1)
(2)
(5)
(2)
(2)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(5)
(1)
(1)
(1)
(4)
(2)
(1)
(1)
(11)
(2)
(12)
(1)
(3)
(11)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(6)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(2)
(2)
(2)
(2)
(1)
(4)
(15)
(8)
(1)
(1)
(1)
(2)
(3)
(5)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(20)
(2)
(1)
(1)
(1)
(2)
(15)
(1)
(6)
(1)
(38)
(16)
(5)
(1)
(7)
(8)
(20)
(8)
(1)
(6)
(1)
(1)
(1)
(2)
(7)
(8)
(3)
(2)
(2)
(9)
(4)
(2)
(15)
(2)
(2)
(2)
(2)
(2)
(6)
(3)
(9)
(10)
(15)
(3)
(2)
(3)
(2)
(18)
(2)
(11)
(3)
(7)
(6)
(3)
(14)
(2)
(3)
(15)
(5)
(3)
(5)
(8)
(2)
(8)
(76)
(2)
(4)
(7)
(2)
(4)
(2)
(2)
(2)
(2)
(2)
(2)
(10)
(26)
(12)
(4)
(25)
(25)
(10)
(4)
(2)
(5)
(2)
(2)
(2)
(6)
(5)
(18)
(2)
(12)
(2)
(3)
(3)
(6)
(2)
(3)
(2)
(2)
(6)
(2)
(2)
(3)
(5)
(7)
(3)
(4)
(4)
(2)
(3)
(4)
(2)
(2)
(3)
(2)
(2)
(2)
(3)
(2)
(10)
(2)
(3)
(4)
(4)
(2)
(3)
(3)
(8)
(2)
(15)
(7)
(2)
(2)
(8)
(2)
(15)
(14)
(13)
(10)
(9)
(3)
(7)
(3)
(13)
(10)
(9)
(9)
(5)
(2)
(2)
(20)
(2)
(4)
(2)
(5)
(2)
(11)
(2)
(2)
(2)
(3)
(4)
(2)
(2)
(4)
(11)
(2)
(2)
(2)
(2)
(74)
(3)
(3)
(3)
(2)
(2)
(2)
(6)
(3)
(2)
(2)
(3)
(23)
(8)
(5)
(29)
(11)
(3)
(16)
(3)
(2)
(2)
(7)
(2)
(64)
(44)
(3)
(6)
(6)
(4)
(4)
(6)
(6)
(2)
(2)
(5)
(6)
(2)
(2)
(3)
(5)
(2)
(2)
(2)
(4)
(12)
(4)
(17)
(7)
(22)
(5)
(2)
(4)
(3)
(3)
(19)
(4)
(2)
(15)
(8)
(2)
(8)
(5)
(2)
(6)
(5)
(2)
(3)
(2)
(2)
(2)
(7)
(2)
(4)
(2)
(2)
(3)
(3)
(4)
(9)
(7)
(2)
(10)
(2)
(7)
(4)
(6)
(2)
(3)
(3)
(9)
(2)
(7)
(2)
(20)
(3)
(4)
(5)
(2)
(2)
(3)
(2)
(8)
(3)
(2)
(2)
(2)
(10)
(2)
(2)
(24)
(3)
(73)
(57)
(8)
(13)
(11)
(6)
(10)
(3)
(2)
(2)
(2)
(7)
(2)
(2)
(3)
(2)
(2)
(2)
(2)
(4)
(5)
(3)
(3)
(6)
(8)
(3)
(5)
(3)
(4)
(52)
(8)
(2)
(2)
(6)
(3)
(2)
(48)
(30)
(46)
(30)
(4)
(17)
(5)
(7)
(16)
(3)
(3)
(24)
(5)
(2)
(39)
(2)
(3)
(2)
(2)
(2)
(2)
(2)
(3)
(2)
(2)
(2)
(2)
(3)
(8)
(3)
(2)
(2)
(2)
(2)
(2)
(2)
(2)
(3)
(13)
(5)
(7)
(2)
(12)
(6)
(2)
(2)
(3)
(2)
(3)
(7)
(2)
(4)
(2)
(2)
(6)
(10)
(3)
(2)
(4)
(10)
(2)
(3)
(2)
(2)
(2)
(2)
(2)
(2)
(5)
(2)
(7)
(3)
(5)
(3)
(7)
(2)
(3)
(2)
(2)
(3)
(2)
(21)
(23)
(2)
(5)
(4)
(2)
(4)
(28)
(5)
(6)
(2)
(9)
(2)
(5)
(2)
(2)
(11)
(14)
(7)
(2)
(6)
(4)
(3)
(2)
(13)
(17)
(11)
(14)
(17)
(16)
(8)
(7)
(18)
(12)
(2)
(2)
(4)
(4)
(2)
(4)
(6)
(2)
(2)
(4)
(5)
(11)
(5)
(2)
(2)
(2)
(11)
(3)
(3)
(40)
(3)
(9)
(15)
(6)
(12)
(42)
(2)
(11)
(3)
(2)
(2)
(2)
(5)
(5)
(4)
(12)
(7)
(6)
(4)
(6)
(2)
(6)
(20)
(3)
(2)
(2)
(3)
(4)
(2)
(2)
(4)
(6)
(5)
(2)
(2)
(10)
(8)
(2)
(2)
(2)
(12)
(2)
(3)
(2)
(4)
(3)
(3)
(4)
(3)
(2)
(2)
(7)
(2)
(7)
(2)
(3)
(2)
(4)
(5)
(59)
(4)
(2)
(2)
(59)
(96)
(2)
(12)
(2)
(3)
(2)
(3)
(2)
(6)
(2)
(9)
(4)
(4)
(2)
(2)
(4)
(7)
(2)
(2)
(18)
(11)
(3)
(4)
(46)
(3)
(3)
(3)
(2)
(2)
(2)
(3)
(6)
(12)
(2)
(9)
(14)
(2)
(2)
(20)
(23)
(8)
(9)
(3)
(2)
(8)
(8)
(3)
(4)
(3)
(4)
(2)
(2)
(6)
(2)
(2)
(3)
(2)
(20)
(4)
(20)
(3)
(11)
(9)
(28)
(8)
(44)
(4)
(2)
(2)
(2)
(2)
(3)
(2)
(4)
(2)
(3)
0 of 1000
(80)
(1)
(6)
0 of 3
Showing 241 - 260 of 9438 results
  • Severe WorkRelated Injuries in the Oil and Gas Extraction Industry 32 Federal Occupational Safety and Health Administration Jurisdictions United States January 2015July 2022
    Severe Work-Related Injuries in the Oil and Gas Extraction Industry – 32 Federal Occupational Safety and Health Administration Jurisdictions, United States, January 2015–July 2022
    Parasram, Vidisha ;
    Reichard, Audrey A.
    2024/02/08 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    What is already known about this topic? Oil and gas extraction (OGE) industry contract workers incur more work-related severe injuries compared with workers in other industries, based on data from the Occupational Safety and Health Administration. What is added by this report? During January 2015-July 2022, 32 jurisdictions reported 2,101 severe in ...
    Public Domain
  • MMWR Morbidity and Mortality Weekly Report Vol 73 No 4 February 1 2024
    MMWR. Morbidity and Mortality Weekly Report, Vol. 73, No. 4, February 1, 2024
    Centers for Disease Control and Prevention (U.S.)
    02/01/2024 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    Surveillance for Acute Flaccid Myelitis ― United States, 2018–2022 /Erin R. Whitehouse; Adriana Lopez; Randall English et al.Early Estimates of Updated 2023–2024 (Monovalent XBB.1.5) COVID-19 Vaccine Effectiveness Against Symptomatic SARS-CoV-2 Infection Attributable to Co-Circulating Omicron Variants Among Immunocompetent Adults — Increasing Commu ...
    Public Domain
  • Supplementary Table Effectiveness of 20232024 Monovalent COVID19 Vaccine Against Symptomatic SARSCoV2 Infection Compared to Receipt of Bivalent Vaccination or Receipt of No Vaccination or Original Monovalent Vaccination Only by Age Group and Interval Since Last Dose Increasing Community Access to Testing Program United States September 2023January 2024
    Supplementary Table. Effectiveness of 2023–2024 Monovalent COVID-19 Vaccine Against Symptomatic SARS-CoV-2 Infection Compared to Receipt of Bivalent Vaccination or Receipt of No Vaccination or Original Monovalent Vaccination Only, by Age Group and Interval Since Last Dose — Increasing Community Access to Testing Program, United States, September 2023–January 2024
    Centers for Disease Control and Prevention (U.S.)
    02/01/2024 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    No Description
    Public Domain
  • Supplementary Figure Trends in Estimated Proportions of SARSCoV2 Reverse TranscriptionPolymerase Chain Reaction Test Results With SGene Target Presence and Variant Proportions and Nowcast Projections FromGenomic Surveillance Classified by SGene Target Presence or SGene Target Failure United States September 27 2023January 20 2024
    Supplementary Figure. Trends in Estimated Proportions of SARS-CoV-2 Reverse Transcription–Polymerase Chain Reaction Test Results With S-Gene Target Presence and Variant Proportions and Nowcast Projections FromGenomic Surveillance Classified by S-Gene Target Presence or S-Gene Target Failure — United States, September 27, 2023–January 20, 2024
    Centers for Disease Control and Prevention (U.S.)
    02/01/2024 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    No Description
    Public Domain
  • Tabla Suplementaria Caractersticas de Los Casos de Dengue Y Las Muertes Per Del 1o de Enero Al 29 de Julio 2023
    Tabla Suplementaria. Características de Los Casos de Dengue Y Las Muertes, Perú, Del 1.o de Enero Al 29 de Julio, 2023
    Centers for Disease Control and Prevention (U.S.)
    02/01/2024 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    No Description
    Public Domain
  • Supplementary Table Characteristics of Dengue Cases and Deaths Peru January 1July 29 2023
    Supplementary Table. Characteristics of Dengue Cases and Deaths — Peru, January 1–July 29, 2023
    Centers for Disease Control and Prevention (U.S.)
    02/01/2024 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    No Description
    Public Domain
  • National HIV Behavioral Surveillance Among Transgender Women Seven Urban Areas United States 20192020 Supplementary Interview Guide NHBSTrans Surveillance Evaluation
    National HIV Behavioral Surveillance Among Transgender Women — Seven Urban Areas, United States, 2019–2020: Supplementary Interview Guide: NHBS-Trans Surveillance Evaluation
    Centers for Disease Control and Prevention (U.S.)
    01/26/2024 | Supplements: Morbidity and Mortality Weekly Report (MMWR)
    No Description
    Public Domain
  • MMWR Morbidity and Mortality Weekly Report Vol 73 No 3 January 25 2024
    MMWR. Morbidity and Mortality Weekly Report, Vol. 73, No. 3, January 25, 2024
    Centers for Disease Control and Prevention (U.S.)
    01/25/2024 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    Prevalence of Cardiometabolic Diseases Among Racial and Ethnic Subgroups in Adults — Behavioral Risk Factor Surveillance System, United States, 2013–2021 / Alain K. Koyama; Kai McKeever Bullard; Fang Xu et al.Underuse of Antiviral Drugs to Prevent Progression to Severe COVID-19 — Veterans Health Administration, March–September 2022 / Paul A. Monach ...
    Public Domain
  • Supplementary Table Characteristics of COVID19Vaccinated Veterans With MildtoModerate COVID19 and Selected Immunosuppressive Conditions by Receipt or Non Receipt of an Antiviral Medication N 1196 Veterans Health Administration United States MarchSeptember 2022
    Supplementary Table. Characteristics of COVID-19–Vaccinated Veterans With Mild-to-Moderate COVID-19 and Selected Immunosuppressive Conditions, by Receipt or Non- Receipt of an Antiviral Medication (N = 1,196) — Veterans Health Administration, United States, March–September 2022
    Centers for Disease Control and Prevention (U.S.)
    01/25/2024 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    No Description
    Public Domain
  • Morbidity and Mortality Weekly Report Supplement January 25 2024 Vol 73 No 1
    Morbidity and Mortality Weekly Report: Supplement, January 25, 2024 / Vol. 73 / No. 1
    Centers for Disease Control and Prevention (U.S.)
    2024/01/25 | Supplements: Morbidity and Mortality Weekly Report (MMWR)
    Transgender women, especially transgender women of color, are disproportionately affected by HIV. However, no surveillance system collects data on HIV risk factors among this population. To address this gap, CDC developed a surveillance system entitled National HIV Behavioral Surveillance Among Transgender Women (NHBS-Trans) to assess behavioral an ...
    Public Domain
  • MMWR Morbidity and Mortality Weekly Report Vol 73 No 2 January 18 2024
    MMWR. Morbidity and Mortality Weekly Report, Vol. 73, No. 2, January 18, 2024
    Centers for Disease Control and Prevention (U.S.)
    01/18/2024 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    Cannabis Use Among Students in Grades 8, 10, and 12, by Sex — King County, Washington, 2008–2021 / Precious Esie; Myduc TaPseudomonas Infection Outbreak Associated with a Hotel Swimming Pool — Maine, March 2023 / Liz Lamere; Emer Smith; Heather Grieser2 et al.Detecting Mpox Cases Through Wastewater Surveillance — United States, August 2022–May 2023 ...
    Public Domain
  • Supplementary Table Weighted prevalence of current and frequent cannabis use by sex and sexbased prevalence differences by survey year and grade Washington Healthy Youth Survey King County 20082021
    Supplementary Table. Weighted* prevalence of current† and frequent§ cannabis use, by sex and sex-based prevalence differences, by survey year and grade — Washington Healthy Youth Survey, King County, 2008–2021
    January 18, 2024 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    Supplementary tables for Sex-specific Differences in Cannabis Use Among Students in Grades 8, 10, and 12 — King County, Washington, 2008–2021
    Public Domain
  • Notice to Readers Change in Publication Date of MMWR Series
    Notice to Readers: Change in Publication Date of MMWR Series
    Centers for Disease Control and Prevention (U.S.)
    01/11/2024 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    No Description
    Supporting Files Public Domain
  • Supplementary Table 1 Vaccine Effectiveness of Bivalent Compared with Effectiveness of Original Monovalent Vaccination Against COVID19related Thromboembolic Events Among Medicare Beneficiaries Aged 65 Years with Immunocompromise and Beneficiaries Aged 18 Years with End Stage Renal Disease Receiving Dialysis with Immunocompromise by Age Group and Time Since Vaccination United States September 2022March 2023
    Supplementary Table 1. Vaccine Effectiveness of Bivalent Compared with Effectiveness of Original Monovalent Vaccination Against COVID-19-related Thromboembolic Events Among Medicare Beneficiaries Aged ≥65 Years with Immunocompromise and Beneficiaries Aged ≥18 Years with End Stage Renal Disease Receiving Dialysis with Immunocompromise, by Age Group and Time Since Vaccination — United States, September 2022–March 2023
    January 11, 2024 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    No Description
    Public Domain
  • Supplementary Table 2 Vaccine Effectiveness of Bivalent Compared with Effectiveness of Original Monovalent Vaccination Against Allcause Thromboembolic Events Among Immunocompetent Medicare Beneficiaries Aged 65 Years and Beneficiaries Aged 18 Years with End Stage Renal Disease Receiving Dialysis Without Additional Immunocompromising Conditions by Age Group and Time Since Vaccination United States September 2022March 2023
    Supplementary Table 2. Vaccine Effectiveness of Bivalent Compared with Effectiveness of Original Monovalent Vaccination Against All-cause Thromboembolic Events Among Immunocompetent Medicare Beneficiaries Aged ≥65 Years and Beneficiaries Aged ≥18 Years with End Stage Renal Disease Receiving Dialysis Without Additional Immunocompromising Conditions, by Age Group and Time Since Vaccination — United States, September 2022–March 2023
    January 11, 2024 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    No Description
    Public Domain
  • MMWR Morbidity and Mortality Weekly Report Vol 73 No 1 January 11 2024
    MMWR. Morbidity and Mortality Weekly Report, Vol. 73, No. 1, January 11, 2024
    Centers for Disease Control and Prevention (U.S.)
    01/11/2024 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    Topical Antifungal Prescribing for Medicare Part D Beneficiaries — United States, 2021 / Kaitlin Benedict; Dallas J. Smith; Tom Chiller et al.Advisory Committee on Immunization Practices Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger — United States, 2024 / A. Patricia Wodi; Neil Murthy; Veronica V. McNally ...
    Public Domain
  • SARSCoV2 Rebound with and Without Use of COVID19 Oral Antivirals
    SARS-CoV-2 Rebound with and Without Use of COVID-19 Oral Antivirals
    Centers for Disease Control and Prevention (U.S.)
    12/22/2023 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    No Description
    Public Domain
  • Supplementary Table Influenza Updated COVID19 and RSV Vaccination Status and Intent for Vaccination Among Adults by Demographic Characteristics National Immunization SurveyAdult COVID Module United States December 39 2023
    Supplementary Table. Influenza, Updated COVID-19, and RSV Vaccination Status and Intent for Vaccination Among Adults by Demographic Characteristics, National Immunization Survey-Adult COVID Module, United States, December 3–9, 2023
    Centers for Disease Control and Prevention (U.S.)
    12/22/2023 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    No Description
    Supporting Files Public Domain
  • Supplementary Table Baseline Demographic and Disease Characteristics of Evaluation of Protease Inhibition for COVID19 in HighRisk Patients EPICHR and Evaluation of Protease Inhibition for COVID19 in StandardRisk Patients EPICSR Study Participants United States and International Sites 20212022
    Supplementary Table. Baseline Demographic and Disease Characteristics of Evaluation of Protease Inhibition for COVID-19 in High-Risk Patients (EPIC-HR) and Evaluation of Protease Inhibition for COVID-19 in Standard-Risk Patients (EPIC-SR) Study Participants — United States and International Sites, 2021–2022
    Centers for Disease Control and Prevention (U.S.)
    12/22/2023 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    No Description
    Public Domain
  • Supplementary Figure Viral RNA Shedding Levels for Individual Subjects With Viral RNA Rebound Among Subjects in the EPICHR Trial Who Met the Definitions of Posttreatment Viral RNA Rebound on Day 10 a or 14 B Those Who Met the Definition of Viral RNA Rebound During the Treatment Period From Day 3 to Day 5 C D Those in the EPICSR 2021PreOmicron E and 2022Omicron Enrollment Periods F Who Met the Definition of Day 10 or Day 14 Viral RNA Rebound
    Supplementary Figure. Viral RNA Shedding Levels for Individual Subjects With Viral RNA Rebound Among Subjects in the EPIC-HR Trial Who Met the Definitions of Posttreatment Viral RNA Rebound on Day 10 (a) or 14 (B); Those Who Met the Definition of Viral RNA Rebound During the Treatment Period From Day 3 to Day 5* (C, D); Those in the EPIC-SR 2021/Pre-Omicron (E) and 2022/Omicron Enrollment Periods (F), Who Met the Definition of Day 10 or Day 14 Viral RNA Rebound
    Centers for Disease Control and Prevention (U.S.)
    12/22/2023 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    No Description
    Public Domain
241 - 260 / 9438